Without adjusting for US population and growth and other de-risked ( due to funding) pipeline
remember 3 things:
1. Japan sales as it is today already have 300 000 prescribtions annually...and still Growing at over 45% yoy!!!
growth
just this 300 000 prescribtions- would justify aud3bln valuation as it gives us over 200mln Sales p.a. and still Growing !
2. US 3x population gives us upside of 3x...this investor gets for free, assuming you believe in at least 300 000 prescribtions p.a
3. Japan growth is still strong - investor who just believes in 300k prescriptions not more will get it dor free
i will not go to de- risked pipeline of products ( since we will have $$ to fund its Ph3 and Ph2) - this in its own would worth at least 500mln as being advanced...
so, investor buying today gets upside to $2 per share just on 300k prescriptionswe know today, free growth based on japan 45% yoy growth, free 3x upside due to US population, and free upside due to derisked ( funded) pipeline of other derm advanced products...
on FDA approval and continuing confirmation of Japan growth we should see$1
i call it $3 per share as a base range valuation but i see it higher!
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-7068
-
- There are more pages in this discussion • 2,204 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 134000 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 650314 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 132500 | 0.375 |
3 | 7752 | 0.370 |
2 | 24000 | 0.365 |
1 | 4166 | 0.360 |
3 | 59669 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 502144 | 15 |
0.385 | 164500 | 4 |
0.390 | 276986 | 11 |
0.395 | 750000 | 5 |
0.400 | 660032 | 20 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
BOT (ASX) Chart |